Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.
about
Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Time-to-event modelling of eff ...... with hepatocellular carcinoma.
@en
Time-to-event modelling of eff ...... with hepatocellular carcinoma.
@nl
type
label
Time-to-event modelling of eff ...... with hepatocellular carcinoma.
@en
Time-to-event modelling of eff ...... with hepatocellular carcinoma.
@nl
prefLabel
Time-to-event modelling of eff ...... with hepatocellular carcinoma.
@en
Time-to-event modelling of eff ...... with hepatocellular carcinoma.
@nl
P2093
P2860
P50
P356
P1476
Time-to-event modelling of eff ...... with hepatocellular carcinoma.
@en
P2093
Cheikh Diack
Ruey-Min Lee
Satofumi Iida
Takehiko Kawanishi
Ya-Chi Chen
P2860
P304
P356
10.1111/BCP.13530
P407
P577
2018-01-30T00:00:00Z